NCT06781125 2025-01-17One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid TumorsImmorna Biotherapeutics, Inc.Phase 1 Not yet recruiting72 enrolled